The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Mammary gland neoplasia in long-term rodent studies.
Open accessAbstract
Breast cancer, the most frequent spontaneous malignancy diagnosed in women in the western world, is continuously increasing in incidence in industrialized nations. Although breast cancer develops in women as the result of a combination of external and endogenous factors such as exposure to ionizing radiation, diet, socioeconomic status, and endocrinologic, familial, or genetic factors, no specific etiologic agent(s) or the mechanisms responsible of the disease has been identified as yet. Thus, experimental models that exhibit the same complex interactions are needed for testing various mechanisms and for assessing the carcinogenic potential of given chemicals. Rodent mammary carcinomas represent such a model to a great extent because, in these species, mammary cancer is a multistep complex process that can be induced by either chemicals, radiation, viruses, or genetic factors. Long-term studies in rodent models have been particularly useful for dissecting the initiation, promotion, and progression steps of carcinogenesis. The susceptibility of the rodent mammary gland to develop neoplasms has made this organ a unique target for testing the carcinogenic potential of specific genotoxic chemicals and environmental agents. Mammary tumors induced by indirect- or direct-acting carcinogens such as 7, 12-dimethlbenz(a)anthracene or N-methyl-N-nitrosourea are, in general, hormone dependent adenocarcinomas whose incidence, number of tumors per animal, tumor latency, and tumor type are influenced by the age, reproductive history, and endocarinologic milieu of the host at the time of carcinogen exposure. Rodent models are informative in the absence of human data. They have provided valuable information on the dose and route of administration to be used and optimal host conditions for eliciting maximal tumorigenic response. Studies of the influence of normal gland development on the pathogenesis of chemically induced mammary carcinomas have clarified the role of differentiation in cancer initiation. Comparative studies with the development of the human breast and the pathogenesis of breast cancer have contributed to validate rodent-to-human extrapolations. However, it has not been definitively established what type of information is necessary for human risk assessment, whether currently toxicity testing methodologies are sufficient for fulfilling those needs, or whether treatment-induced tumorigenic responses in rodents are predictive of potential human risk. An alternative to the traditional bioassays are mechanism-based toxicology and molecular and cellular approaches, combined with comparative in vitro systems. These approaches might allow the rapid screen of chemicals for setting priorities for further studies to determine the dose-response relationship for chemical effects at low doses, to assess effects other than mutagenesis and/or tumorigenesis, or to establish qualitative and quantitative relationships of biomarkers to toxic effects. Until there is enough information on the predictive value of mechanism-based toxicology for risk assessment, this approach should be used in conjunction with and validated by the traditional in vivo long-term bioassays.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Wingo, P. A., Tong, T., & Bolden, S. (1995) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.45.1.8 · Cited by 1,410
Age at first birth and breast cancer risk.
MacMahon, B., Cole, P. T., Lin, T. M., Lowe, C. R., Mirra, A. P., Ravnihar, B., Salber, E. J., Valaoras, V. G., & Yuasa, S. (1970) · Europe PMC (PubMed Central) · Cited by 1,057
Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk
Pike, M. C., Spicer, D. V., Dahmoush, L., & Press, M. F. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036102 · Cited by 1,010
α-lnhibin is a tumour-suppressor gene with gonadal specificity in mice
Matzuk, M. M., Finegold, M. J., Su, J.-G. J., Hsueh, A. J. W., & Bradley, A. (1992) · Nature · doi:10.1038/360313a0 · Cited by 890
Folkman, J. (1986) · PubMed · Cited by 863
YING, S.-Y. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-2-267 · Cited by 820
Mammary Cancer Induced by a Single Feeding of Polynuclear Hydrocarbons, and its Suppression
HUGGINS, C., GRAND, L. C., & BRILLANTES, F. P. (1961) · Nature · doi:10.1038/189204a0 · Cited by 786
(1975) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/55.2.231 · Cited by 750
Differentiation of the mammary gland and susceptibility to carcinogenesis
Russo, J., Tay, L. K., & Russo, I. H. (1982) · Breast Cancer Research and Treatment · doi:10.1007/bf01805718 · Cited by 629
Self-citation
Cited by
Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland
Johnson, M. D., Kenney, N., Stoica, A., Hilakivi-Clarke, L., Singh, B., Chepko, G., Clarke, R., Sholler, P. F., Lirio, A. A., Foss, C., et al. (2003) · Nature Medicine · doi:10.1038/nm902 · Cited by 585
The role of estrogen in the initiation of breast cancer
Russo, J., & Russo, I. H. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.004 · Cited by 575
Self-citationA review of the carcinogenic potential of bisphenol A
Seachrist, D. D., Bonk, K. W., Ho, S.-M., Prins, G. S., Soto, A. M., & Keri, R. A. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2015.09.006 · Cited by 490
(2001) · PubMed · Cited by 437
An Atlas of Mouse Mammary Gland Development
Richert, M. M., Schwertfeger, K. L., Ryder, J. W., & Anderson, S. M. (2000) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1026499523505 · Cited by 436
The protective role of pregnancy in breast cancer
Russo, J., Moral, R., Balogh, G. A., Mailo, D., & Russo, I. H. (2005) · Breast Cancer Research · doi:10.1186/bcr1029 · Cited by 400
Self-citationRadiation and breast cancer: a review of current evidence
Ronckers, C. M., Erdmann, C. A., & Land, C. E. (2004) · Breast Cancer Research · doi:10.1186/bcr970 · Cited by 366
Environmental pollutants and breast cancer: Epidemiologic studies
Brody, J. G., Moysich, K. B., Humblet, O., Attfield, K. R., Beehler, G. P., & Rudel, R. A. (2007) · Cancer · doi:10.1002/cncr.22655 · Cited by 375
Mammary Gland Development and Tumorigenesis in Estrogen Receptor Knockout Mice
Bocchinfuso, W. P., & Korach, K. S. (1997) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1026339111278 · Cited by 362
Bisphenol A (BPA) and cell signaling pathways
Murata, M., & Kang, J.-H. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.002 · Cited by 361
Role of Hormones in Mammary Cancer Initiation and Progression
Russo, I. H., & Russo, J. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018770218022 · Cited by 337
Self-citationDevelopment of the human breast
Russo, J., & Russo, I. H. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.04.011 · Cited by 324
Self-citationMurray, T. J., Maffini, M. V., Ucci, A. A., Sonnenschein, C., & Soto, A. M. (2007) · Reproductive Toxicology · doi:10.1016/j.reprotox.2006.10.002 · Cited by 323
Environmental pollutants and breast cancer.
Brody, J. G., & Rudel, R. A. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6310 · Cited by 307
Circadian Disruption and Breast Cancer: From Melatonin to Clock Genes
Stevens, R. G. (2005) · Epidemiology · doi:10.1097/01.ede.0000152525.21924.54 · Cited by 296
Feng, Y., Manka, D., Wagner, K.-U., & Khan, S. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706933104 · Cited by 274
Wagner, K.-U., Boulanger, C. A., Henry, M. D., Sgagias, M., Hennighausen, L., & Smith, G. H. (2002) · Development · doi:10.1242/dev.129.6.1377 · Cited by 274
Epidemiology and Pathophysiology of Alcohol and Breast Cancer: Update 2012
Seitz, H. K., Pelucchi, C., Bagnardi, V., & Vecchia, C. L. (2012) · Alcohol and Alcoholism · doi:10.1093/alcalc/ags011 · Cited by 258
Alcohol Use and Breast Cancer: A Critical Review
Shield, K. D., Soerjomataram, I., & Rehm, J. (2016) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13071 · Cited by 204
Laverty, H. G., Wakefield, L. M., Occleston, N. L., O’Kane, S., & Ferguson, M. W. J. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.07.002 · Cited by 110
Dhimolea, E., Wadia, P. R., Murray, T. J., Settles, M. L., Treitman, J. D., Sonnenschein, C., Shioda, T., & Soto, A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099800 · Cited by 104
Metadata
- Authors
- Russo, I. H., & Russo, J.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 1996-09
- Volume
- 104
- Issue
- 9
- Pages
- 938-967
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2047741256
- Cited by
- 433
- References
- 104
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.